|
|
Volumn 303, Issue 3, 2010, Pages 213-214
|
|
Epigenetic therapies offer new approach to fighting cancer at the genetic level
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
AZACITIDINE;
CYTOTOXIC AGENT;
DNA;
ENZYME INHIBITOR;
HISTONE;
HISTONE DEACETYLASE;
ROMIDEPSIN;
VORINOSTAT;
ACETYLATION;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW SUPPRESSION;
CANCER CELL;
CANCER CELL CULTURE;
CANCER CONTROL;
CANCER PREVENTION;
CANCER RESEARCH;
CANCER THERAPY;
CARCINOGENESIS;
CELL CYCLE REGULATION;
CELL GROWTH;
CHROMATIN ASSEMBLY AND DISASSEMBLY;
DEMETHYLATION;
DNA METHYLATION;
DRUG APPROVAL;
DRUG TARGETING;
EPIGENETICS;
GENE ACTIVATION;
GENE EXPRESSION;
GENE SILENCING;
GENE THERAPY;
HEMATOLOGIC DISEASE;
LEUKEMIA;
LUNG NON SMALL CELL CANCER;
METHYLATION;
MYELODYSPLASTIC SYNDROME;
ONCOLOGY;
PRIORITY JOURNAL;
PROTEIN DEFECT;
SHORT SURVEY;
SOLID TUMOR;
T CELL LYMPHOMA;
TRANSCRIPTION REGULATION;
TREATMENT RESPONSE;
TUMOR SUPPRESSOR GENE;
|
|
EID: 74549130570
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2009.1914 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|